Bacterial Pathogenesis Research Group
5,484,773 -- Treatment of Antibiotic-Associated Diarrhea.
5,635,606 -- A Method of Removing Toxin A.
5,858,698 -- Methods for detection of enteropathogenic e. coli.
5,922,848 -- Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin. Previously issued, related patents: 5,888,750.
5,939,397 -- Treatment of cholera. Previously issued, related patents: 5,817,633, 5,811,409, and 5,661,131.
5,955,379 -- Biosensor device and method.
5,955,449 -- Diagnosis and treatment of bacterial dysentery. Previously issued, related patents: 5,679,653 and 5,620,858 -- Method of Removing Shiga-like Toxins from Biological Samples.
6,069,137 -- Treatment of traveller's diarrhea. Previously issued, related patents: 5,891,860, 5,637,576, and 5,627,163.
6,168,928 -- Modification of pertussis toxin. Previously issued, related patents: 6,018,022, 5,977,304 , 5,965,385 , and 5,856,122.
6,224,891 -- Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions. Previously issued, related patents: 6,121,242 -- Treatment of bacterial dysentery, and 5,849,714 .
6,245,883 -- Anti-flammatory carbohydrate binding-peptides. Previously issued, related patents: 5,833,990 -- Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides, 5,736,143, 5,747,040, and 5,453,272 -- Lectin-Derived Carbohydrate-Binding Peptides.
6,262,037 -- Pharmaceutical compositions for the amelioration of enteropathogenic E. coli infection.
6,291,435 -- Treatment of diarrhea caused by enteropathogenic Escherichia coli.
6,310,043 -- Treatment of bacterial infections. Previously issued, related patents: 5,962,423 -- Treatment of bacterial dysentery.
6,465,435 -- Treatment of C. difficile toxin B associated conditions. Previously issued, related patents: 6,358,930, 6,107,282, and 6,013,635.